IHC analysis of paraffin-embedded human breast carcinoma, using p53 (Phospho-Ser6) Antibody. The picture is blocked with the phospho peptide.
WB analysis of lysates from COS7 cells treated with H2O2 100uM 30 min, using p53 (Phospho-Ser6) Antibody. The lane on the right is blocked with the phospho peptide.
Target
Alternative Names
TP53; tumor protein p53; P53; BCC7; LFS1; TRP53; cellular tumor antigen p53; antigen NY-CO-13; tumor protein 53; phosphoprotein p53; p53 tumor suppressor; mutant tumor protein 53; transformation-related protein 53;
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More
Citations
Have you cited CABT-L4171 in a publication? Let us know and earn a reward for your research.
Abrisqueta, P; Crespo, M; et al. Personalizing treatment for chronic lymphocytic leukemia. EXPERT REVIEW OF HEMATOLOGY 4:27-35(2011).
Helland, A; Kraggerud, SM; et al. Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival. INTERNATIONAL JOURNAL OF CANCER 88:217-222(2000).
IHC analysis of paraffin-embedded human breast carcinoma, using p53 (Phospho-Ser6) Antibody. The picture is blocked with the phospho peptide.
WB analysis of lysates from COS7 cells treated with H2O2 100uM 30 min, using p53 (Phospho-Ser6) Antibody. The lane on the right is blocked with the phospho peptide.
My Review for Rabbit Anti-Human TP53 (Phospho-Ser6) polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.